This new referral pathway is part of a research pilot project that aims to support patients and primary health care providers by facilitating access to care and information related to lung nodules and lung cancer screening.
Key points
- This pilot project will run from July 2025 to June 2026
- Healthcare providers must provide patients with a copy of our participant opt-out information sheet at the time of referral to our program. The sheet will also be sent to patients who are attending clinic appointments with their appointment correspondence
- Patients who decline participation in this pathway should be referred via our existing Respiratory Outpatient Clinic referral pathway stating they have declined the lung nodule and lung cancer screening pathway
- Referring healthcare providers can contact our lung nodule and lung cancer screening nurse hotline for telephone and email advice
What we do
This pilot research project has a streamlined referral process that will allow patients and primary healthcare providers to access the following resources:
- Dedicated lung nodule and lung cancer screening nurse support (via telephone and email) for referring healthcare providers
- Streamlined non-screen detected lung nodule clinics
- Streamlined lung cancer screening high-risk findings clinics with a respiratory physician linked to a multidisciplinary team (as recommended by low dose computed tomography (LDCT) screening report)
- Streamlined lung cancer screening-detected respiratory additional finding (as recommended by LDCT screening report)
The streamlined referral pathway is part of a pilot project that will run from July 2025 to June 2026. It is funded by the Victorian Medical Research Acceleration Fund and the Royal Melbourne Hospital Foundation.
Advice hotline for referrers
Referring health care providers can contact our lung nodule and lung cancer screening nurse advice hotline:
- call 0455 409 806, or
- email rmhlungnoduleandscreeningreferrals@mh.org.au
Our response time will be within 48 hours from Monday to Friday.
We offer advice regarding:
- the lung cancer screening program
- screen-detected abnormalities
- non-screen detected pulmonary nodules
- quitting smoking
We also provide written communication and documentation for your records as part of this service.
Hotline requirements
To provide clinical advice, we will need the following information at the time of contact:
- Referring provider name, number and practice address
- Patient name, date of birth, address and RMH UR number if applicable, as well as relevant clinical details including clinical history and imaging if requesting specific advice
- Confirmation that the patient has received the study participant opt-out information sheet (PDF) at the time of referral and is aware of the contact
Urgent clinical advice
For urgent clinical advice, please contact our Respiratory Registrar via the RMH Switchboard on (03) 9342 7000.
Outpatient clinic referrals
We offer outpatient clinics (including telehealth) for the following conditions:
- Non-screen detected pulmonary nodules
- High-risk lung cancer screening results requiring Respiratory Physician review linked to a MDT
- Actionable respiratory additional findings detected on lung cancer screening LDCT as part of the National Lung Cancer Screening Program. Please refer to National Lung Cancer Screening Program additional findings guideline for relevant conditions.
This referral pathway does not accept referrals for non-respiratory additional findings detected on the lung cancer screening or additional findings detected on non-lung cancer screening LDCTs.
If further guidance is required, please contact our advice hotline on 0455 409 806 or at rmhlungnoduleandscreeningreferrals@mh.org.au.
For information about appropriate clinics, see our services and clinics list.
How to refer your patient
For outpatient clinic referrals to our lung nodule and lung cancer screening pathway clinics:
- use the RMH referral form or a template from your own system
- please email your referral to rmhlungnoduleandscreeningreferrals@mh.org.au or fax your referral to Specialist Clinics (Outpatients) on (03) 9342 4234
Referral information
Referral requests should include:
- Patient demographic information, contact details and clinical history
- Reason for referral (identify specific clinic required)
- Confirmation patient has received the study participant opt-out information sheet (PDF) at the time of referral
- Patient preference for telehealth or in-person review
- Complete imaging reports including location of any previous scans
- Referring doctor name and provider number
All patients will be contacted by our pathway nurse after we receive the referral. Please include the patient's preferred contact details.
Participant opt-out information sheet
As this is a clinical research program with inclusion of a lung nodule registry, healthcare providers are required to provide patients with a copy of the participant opt-out information sheet (PDF) at the time of referral. It will also be sent to patients who are attending clinic appointments with their appointment correspondence.
Patients who opt-out of the study by signing the information sheet should instead be referred via our standard Respiratory Medicine referral pathway.
Please include a copy of the signed opt-out information sheet with the referral for patients who decline the pathway.
Links & documents
Need to change or cancel your appointment?
Do one of the following:
- Access Health Hub to change the appointment yourself
- Complete our online form and we'll change it for you
- Call us on (03) 9342 7708 and we'll help you over the phone
About the National Lung Cancer Screening Program
The RMH is proud to support the National Lung Cancer Screening Program (NLCSP) as part of Victoria’s network of public lung nodule clinics. These clinics play a vital role in the early detection and management of lung cancer, supporting the assessment and early management of patients with high-risk screening results.
The NLCSP is a free, Commonwealth-funded program designed to detect lung cancer early, when treatment is more effective and survival rates are higher. Eligible community members can be referred for a screening test (low dose CT) at a participating radiology provider by their GP.
To be eligible, individuals must:
- be aged between 50 and 70 years
- be asymptomatic (no signs or symptoms of lung cancer)
- currently smoke or have quit within the past 10 years
- have a history of tobacco cigarette smoking of at least 30 pack-years.